FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The White House has postponed its plan to outlaw menthol cigarettes indefinitely.

2.

Recent research suggests that vitamin supplements may increase the risk of developing cancer.

3.

Researchers have determined that malignancy hibernation will be the next front in the fight against breast cancer.

4.

Citing a cancer risk, the EPA sets a new limit on medical sterilization chemicals.

5.

Tumor-targeting fluorescent bacteria illuminate cancer for precision surgery


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot